Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 82137-016

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 82137-016). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lepu Pharmaceutical Technology Co., Ltd., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Atorvas Tab 01)

Chemical structure diagram of atorvastatin calcium showing its molecular arrangement, including aromatic rings, fluorine substitution, hydroxyl groups, and calcium salt with water molecules (3H2O).*

FDA Label Image

02 (Atorvas Tab 02)

A line graph comparing cumulative incidence percentages over 3.5 years between atorvastatin and placebo groups. The x-axis represents years, and the y-axis shows cumulative incidence (%). Atorvastatin is depicted with a solid line, showing lower cumulative incidence than placebo, which is represented with a dashed line.*

FDA Label Image

03 (Atorvas Tab 03)

A cumulative hazard graph comparing atorvastatin with placebo over up to 5 years of follow-up. The y-axis represents cumulative hazard percentage, and the x-axis shows time to first primary endpoint in years. The graph shows lower cumulative hazard for atorvastatin than placebo, with a hazard ratio of 0.63 (95% CI 0.48-0.83) and a p-value of 0.001, indicating statistical significance.*

FDA Label Image

04 (Atorvas Tab 04)

A Kaplan-Meier curve graph comparing time to first major cardiovascular endpoint over five years for atorvastatin calcium 10 mg and 80 mg tablets. The graph shows percentages of subjects experiencing events, with atorvastatin 10 mg represented by a dashed line and 80 mg by a solid line, including a hazard ratio (HR) of 0.78 with confidence interval and p-value displayed.*

FDA Label Image

Principal Display Panel (10 mg Tablet Bottle Label)

Atorvastatin Calcium 10 mg film-coated tablets label from Lepu Pharmaceutical Technology Co., Ltd. The label indicates 90 tablets in the package with Rx only status. Storage instructions specify controlled room temperature between 20-25°C (68-77°F). Includes a barcode and manufacturer address in Taizhou City, Zhejiang Province, China.*

FDA Label Image

Principal Display Panel (20 mg Tablet Bottle Label)

Label for Atorvastatin Calcium Tablets USP 20 mg, film-coated oral tablets, provided in a container of 90 tablets. Manufactured by Lepu Pharmaceutical Technology Co., Ltd. The label includes storage instructions, dosage reference, and an NDC number 82137-017-01.*

FDA Label Image

Principal Display Panel (40 mg Tablet Bottle Label)

Atorvastatin Calcium 40 mg film-coated tablets label from Lepu Pharmaceutical Technology Co., Ltd. The label indicates a package size of 90 tablets for oral use, with storage instructions at controlled room temperature (20-25°C). It includes the NDC code 82137-018-01 and notes the product is prescription only (Rx only).*

FDA Label Image

Principal Display Panel (80 mg Tablet Bottle Label)

Label for atorvastatin calcium 80 mg tablets, USP, manufactured by Lepu Pharmaceutical Technology Co., Ltd. The label indicates 90 tablets in the package and includes storage instructions (20-25°C). It displays the NDC number 82137-019-01 and notes the product is Rx only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.